Bayer is asking a Missouri court to grant final approval to a $7.25 billion settlement covering roughly 65,000 lawsuits claiming Roundup weedkiller causes non-Hodgkin lymphoma, as Reuters’ Dietrich Knauth reports. Judge Timothy Boyer heard arguments in St. Louis on September 14, 2026 but isn’t expected to rule immediately.
The deal pays $10,000 to $165,000 per claimant, scaled to cancer severity, age at diagnosis and exposure history. It’s Bayer’s second attempt at closing the books on Roundup litigation, after a roughly $10 billion 2020 settlement resolved existing claims but left the company exposed to fresh suits.
Supporters, including attorneys for tens of thousands of class members, argue the deal locks in compensation now that the Supreme Court has upheld EPA’s finding that glyphosate’s label needs no cancer warning. A Monsanto spokesman said the settlement “is fair to all parties and warrants final approval.”
Related on the SLP
Objectors counter the payouts are too low and would trap plaintiffs who’d rather sue individually. The World Health Organization’s cancer research arm called glyphosate a probable carcinogen in 2015; the EPA has repeatedly found no such risk at real-world exposures — a conclusion that a vast majority of other global health agencies agree with.
|
Related on the SLP
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
|
